Formulation And Evaluation Of Carvedilol Liquisolid Tablets

Formulation And Evaluation Of Carvedilol Liquisolid Tablets


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

₹ 3,651

Availability: Out of stock


Delivery :

5% Cashback on all Orders paid using MobiKwik Wallet T&C

Free Krispy Kreme Voucher on all Orders paid using UltraCash Wallet T&C
Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description

The present study enlightens to enhance the dissolution profile, absorption efficiency and bioavailability of water insoluble drugs like carvedilol. A novel “Powder Solution Technology” involves absorption and adsorption efficiency, which makes use of liquid medications admixed with suitable carriers and coating materials and formulated into a free flowing, dry looking, non adherent and compressible powder forms. Based upon a new mathematical model expression improved flow characteristics and hardness of the formulation has been achieved by changing the proportion of carrier and coating material ratio from 20:1 to 5:1. Di calcium phosphate , Avicel ® PH 200 were showing acceptable flow properties compared with Avicel ®PH 101 and Lactose. Higher dissolution rates (98.4%) were observed in Poly ethylene glycol 400 and Avicel ®PH 200 containing liquisolid formulations (F5) compared with marketed product (CARCA® 12.5 mg tablets) 81% drug release. Poly ethylene glycol 400 was showing highest solubility compared with poly ethylene glycol 200, propylene glycol and glycerin. The crystalline state of carvedilol drug state is changed to amorphous state due to liquisolid formation and is confi

Product Specifications
SKU :COC31268
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-07-31
0 Review(s)